Login / Signup

Engineering Mesoscopic 3D tumor Models with A Self-Organizing Vascularized Matrix.

Federica De LorenziNadja HansenBenjamin TheekRasika DawareAlessandro MottaSaskia BreuelRamin NasehiJulian BaumeisterJan SchönebergNatalija StojanovićSaskia von StillfriedMichael VogtGerhard Müller-NewenJochen MaurerAlexandros Marios SofiasTwan LammersHorst FischerFabian Kießling
Published in: Advanced materials (Deerfield Beach, Fla.) (2023)
Advanced in vitro systems such as multicellular spheroids and lab-on-a-chip devices have been developed, but often fall short in reproducing the tissue scale and self-organization of human diseases. We here introduce a bio-printed artificial tumor model with endothelial and stromal cells self-organizing into perfusable and functional vascular structures. Our model uses 3D hydrogel matrices to embed multicellular tumor spheroids, allowing them to grow to mesoscopic scales and to interact with endothelial cells. We show that angiogenic multicellular tumor spheroids promote the growth of a vascular network, which in turn further enhances the growth of co-cultivated tumor spheroids. The self-developed vascular structure infiltrates the tumor spheroids, forms functional connections with the bioprinted endothelium, and can be perfused by erythrocytes and polystyrene microspheres. Moreover, cancer cells migrate spontaneously from the tumor spheroid through the self-assembled vascular network into the fluid flow. Additionally, tumor type specific characteristics of desmoplasia, angiogenesis, and metastatic propensity are preserved between patient-derived samples and tumors derived from this same material growing in our bioreactors. Overall, our modular approach opens up new avenues for studying tumor pathophysiology and cellular interactions in vitro, providing a platform for advanced drug testing while reducing the need for in vivo experimentation. This article is protected by copyright. All rights reserved.
Keyphrases
  • endothelial cells
  • squamous cell carcinoma
  • small cell lung cancer
  • drug delivery
  • emergency department
  • single cell
  • hyaluronic acid
  • adverse drug